Quick Takeaways
- Hyam Levitsky has 2 issuer positions tracked on this page.
- Estimated disclosed ownership value: $2,880,972.
- Recent insider filing activity is available below.
- Info
- Insider Ownership
Insider Trading & Ownership of Hyam Levitsky
- Location
- New York, NY
- Summary
- The estimated net worth of Hyam Levitsky is at least $2,880,972 dollars as of 03 Apr 2024. Hyam Levitsky is the President of R&D of Century Therapeutics, Inc. and owns shares of Century Therapeutics, Inc. (IPSC) stock worth about $2.88M.
- Signature
- /s/ Shawn Glidden, attorney-in-fact
- All Insider Reports
- All Insider Reports
Follow Filing Activity
Follow Hyam Levitsky and return when a new Insider Trading filing changes the record on this page.
This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean.
What Changed
- Largest disclosed position: Century Therapeutics, Inc. ($2,880,972).
- Past-year value change for that position: .
Why This Matters
- This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
- You can cross-check role, issuer, and filing chronology directly against the SEC source.
Source Evidence
Filed on Form 4
See Original Filing
Insider ownership context is sourced from SEC Forms 3, 4, and 5.
Ownership of Hyam Levitsky
| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| IPSC | Century Therapeutics, Inc. | President of R&D | $2,880,972 | 07 Mar 2024 | ||
| REPL | Replimune Group, Inc. | Director | 01 Apr 2024 |
Insider Transactions Reported by Hyam Levitsky:
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.